ArticleOncotarget2017

Combination therapy with capecitabine and temozolomide in patients with low and high grade neuroendocrine tumors, with an exploratory analysis of O

Dwight H Owen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.